On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
876 - 900 of 89.729
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- MDAX Call 31.600,00 20 Nov 2026
- Goldman Sachs
- 20.11.26
- 10,03x
- Analysis
- MDAX Put 33.600,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 12,96x
- Analysis
- EURO STOXX 50 Put 6.300,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 15,10x
- Analysis
- DAX Put 24.700,00 2 Oct 2026
- Goldman Sachs
- 02.10.26
- 47,06x
- Analysis
- DAX Put 21.400,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 7,43x
- Analysis
- EURO STOXX 50 Call 6.900,00 16 Apr 2027
- Goldman Sachs
- 16.04.27
- 11,90x
- Analysis
- S&P500 Call 8.100,00 16 Apr 2027
- Goldman Sachs
- 16.04.27
- 10,10x
- Analysis
- NASDAQ-100 Call 29.100,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 17,56x
- Analysis
- S&P500 Put 7.900,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 15,55x
- Analysis
- DAX Put 26.500,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 26,60x
- Analysis
- NASDAQ-100 Call 32.600,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 13,16x
- Analysis
- DAX Put 25.500,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 35,76x
- Analysis
- DAX Call 27.600,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 46,69x
- Analysis
- DAX Put 26.300,00 2 Oct 2026
- Goldman Sachs
- 02.10.26
- 32,72x
- Analysis
- DAX Put 24.800,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 39,21x
- Analysis
- DAX Put 24.500,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 38,95x
- Analysis
- DAX Call 26.000,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 26,57x
- Analysis
- DAX Call 26.500,00 9 Oct 2026
- Goldman Sachs
- 09.10.26
- 33,07x
- Analysis
- Danaher Call 350,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 4,98x
- Analysis
- Pfizer Call 45,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 4,84x
- Analysis
- Robinhood Call 80,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,48x
- Analysis
- Danaher Call 350,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,85x
- Analysis
- Biontech Se USD Call 160,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,37x
- Analysis
- Biontech Se USD Call 140,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,12x
- Analysis
- Biontech Se USD Call 160,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,55x
- Analysis